查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
水胶体敷料的全球市场:市场规模 - 各原料，各用途，各产品，各终端用户，各地区展望，竞争策略，各市场区隔预测(～2030年)
市场调查报告书
商品编码
1139774

水胶体敷料的全球市场:市场规模 - 各原料，各用途，各产品，各终端用户，各地区展望，竞争策略，各市场区隔预测(～2030年)

Hydrocolloid Dressing Market Size - By Raw Material, By Application, By Product, By End-User - Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球水胶体敷料的市场规模，预计至2030年达到21亿2,000万美元，以5.5％的年复合成长率成长。

先进的伤口护理使用水胶体敷料，有高耐用性，癒合速度快，减轻不舒服，降低感染风险，与周围皮肤的紧贴性等，许多优点。还有创伤部分性癒合时，刚癒合的皮肤完好无损时，成为保护该处避免表面损伤的防护墙。由于这些优点，水胶体敷料的使用在预测期间内预计增加。

本报告提供全球水胶体敷料市场相关调查，市场动态，市场变数及预测，各原料、用途、产品、终端用户、地区分析，企业简介等相关资讯。

目录

第1章 简介

  • 调查范围
  • 市场区隔分析

第2章 调查手法

  • 调查资料来源
  • 市场规模的估计
  • 资料的三角测量

第3章 摘要整理

第4章 市场动态

  • 促进因素，阻碍因素，机会，课题的分析
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
  • 全球水胶体敷料市场:COVID-19影响

第5章 市场变数及预测

  • SWOT分析
    • 优势
    • 弱点
    • 机会
    • 威胁
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 社会形势
    • 技术形势
    • 环境形势
    • 法律上的形势
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 替代品的威胁
    • 新加入厂商的威胁
    • 竞争企业间的敌对关係
  • 热图分析

第6章 全球水胶体敷料市场:各原料，2019年～2030年(100万美元)

  • 合成
  • 天然
  • 半合成

第7章 全球水胶体敷料市场:各用途，2019年～2030年(100万美元)

  • 压力溃疡
  • 静脉性小腿溃疡
  • 糖尿病性溃疡
  • 烧烫伤
  • 其他

第8章 全球水胶体敷料市场:各产品，2019年～2030年(100万美元)

  • 薄板淋酱
  • 非晶质
  • 浸渍淋酱

第9章 全球水胶体敷料市场:各终端用户，2019年～2030年(100万美元)

  • 居家照护环境
  • 医院、诊所
  • 其他

第10章 全球水胶体敷料市场:各地区，2019年～2030年(100万美元)

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的亚太地区
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中东、非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯联合大公国
    • 其他的中东、非洲

第11章 企业简介

  • B. Braun Melsungen AG
    • 企业概要
    • 财务预测
    • 产品概要
    • 最近的开发
  • Cardinal Health
  • Convatec Inc.
  • Covalon Technologies Ltd.
  • Coloplast Corp.
  • Dermarite Industries LLC.
  • Johnson & Johnson
  • Lohmann & Rausche
  • Medline Industries Inc.
  • Paul Hartmann AG
  • Smith & Nephew
  • 3M
简介目录
Product Code: HLCA2211

According to SPER Market Research, the Hydrocolloid Dressing Market estimated to reach USD 2.12 billion by 2030 with a CAGR of 5.5%.

Accidents frequently cause severe bleeding and other injuries, demanding immediate medical attention and surgical procedures to provide patients with relief right away. Because hydrocolloid dressings are efficient for both acute and chronic wounds of various thicknesses, the prevalence of both chronic and acute wounds is thus anticipated to increase.

In lower discharge or necrotic tissue, they promote autolytic debridement. For the treatment of pressure injuries, they adhere successfully to high-friction regions such as the heels and the sacrum. In order to reduce pressure injuries caused by medical devices, hydrocolloid dressings are also used as protective dressings on intubated patients in the ICU. Abrasions and small burns are also treated with them. The aforementioned factors are hence driving the expansion of the hydrocolloid dressing market. Due to its absorbency and ability to provide a barrier of protection over the skin, hydrocolloid technology has long been used in advanced wound care.

The use of additives and recent breakthroughs in hydrocolloid technology has considerably improved patient care. The production of materials using contemporary hydrocolloid extruders is more efficient, reliable, and waste-free. The creation of hybrid materials that mix hydrocolloid and acrylic PSA is another development in the hydrocolloid family. One such development is the exclusive Thin Absorbent Skin Adhesive from Avery Dennison Medical (TASA).

A variety of carrier materials, including polyurethane films and nonwovens, can be coated with adhesive. Standard hydrocolloid adhesives typically range in thickness from 0.3 to 1.0 mm, but TASA is only 0.1 mm thick. Additionally, it encourages absorbency and breathability. Wear periods of up to seven days are possible because of these exceptional fluid-handling characteristics. As a result, these improvements and advancements have created a wide range of new opportunities for a better patient experience, boosting the industry. Using a hydrocolloid dressing for advanced wound care has a number of additional benefits, such as high durability, quicker healing, reduced discomfort, a lower risk of infection, and adherence exclusively to surrounding skin. In addition, hydrocolloids are inexpensive, versatile, and waterproof. When wounds are partially healed or newly healed skin is still intact, they can make an excellent protective barrier to shield the area from potential surface harm. Because of the mentioned advantages offered by hydrocolloid dressings, their use is therefore expected to increase during the projection period.

Impact of COVID-19 on the Global Hydrocolloid Dressing Market:

Doctors and other front-line personnel have greatly benefited from the hydrocolloid dressing's ability to avoid facial pressure and facial markings when wearing medical protective equipment during the COVID-19 epidemic. A layer of semi-permeable hydrocolloid, commonly used for wound healing, can be found inside a film or foam pad that clings to the skin. This is accomplished by using a hydrocolloid dressing. Following the trimming of the hydrocolloid dressing, the adhesive dressing is applied to the skin of the nasal dorsum, cheeks, and forehead, covering the region where the mask and safety goggles would sit. This has a substantial impact on the market expansion of hydrocolloids in the pharmaceutical industry.

Scope of the report

Report Metric Details:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Raw Material, By Application, By Product, By End-User
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
  • Companies Covered: B. Braun Melsungen AG, Cardinal Health, Convatec Inc., Covalon Technologies Ltd., Coloplast Corp., Dermarite Industries LLC., Johnson & Johnson, Lohmann & Rauscher, Medline Industries Inc., Paul Hartmann AG, Smith & Nephew, 3M.

Global Hydrocolloid Dressing Market, By Raw Material:

Based on the Raw Material, Global Hydrocolloid Dressing Market is segmented as; Synthetic, Natural, Semi-Synthetic.

Global Hydrocolloid Dressing Market, By Application:

Based on the Application, Global Hydrocolloid Dressing Market is segmented as; Pressure Ulcer, Venous leg Ulcer, Diabetic Ulcer, Burn Wounds, Others.

Global Hydrocolloid Dressing Market, By Product:

Based on the Product, Global Hydrocolloid Dressing Market is segmented as; Sheet Dressings, Amorphous, Impregnated Dressings.

Global Hydrocolloid Dressing Market, By End-User:

Based on the End-User, Global Hydrocolloid Dressing Market is segmented as; Homecare Settings, Hospitals & Clinics, Others.

Global Hydrocolloid Dressing Market, By Regions:

The Global Hydrocolloid Dressing Market is majorly driven by North-America. During the projected period, North-America is anticipated to have the quickest rate of growth in the worldwide Hydrocolloid Dressing Market.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Hydrocolloid Dressing Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Hydrocolloid Dressing Market , By Raw Material, 2019-2030 (USD Million)

  • 6.1. Synthetic
  • 6.2. Natural
  • 6.3. Semi-Synthetic

7. Global Hydrocolloid Dressing Market , By Application, 2019-2030 (USD Million)

  • 7.1. Pressure Ulcer
  • 7.2. Venous leg Ulcer
  • 7.3. Diabetic Ulcer
  • 7.4. Burn Wounds
  • 7.5. Others

8. Global Hydrocolloid Dressing Market , By Product, 2019-2030 (USD Million)

  • 8.1. Sheet Dressings
  • 8.2. Amorphous
  • 8.3. Impregnated Dressings

9. Global Hydrocolloid Dressing Market , By End-User, 2019-2030 (USD Million)

  • 9.1. Homecare Settings
  • 9.2. Hospitals & Clinics
  • 9.3. Others

10. Global Hydrocolloid Dressing Market , By Region , 2019-2030 (USD Million)

  • 10.1. North America
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Mexico
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. United Kingdom
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of Asia-Pacific
  • 10.4. South America
    • 10.4.1. Brazil
    • 10.4.2. Argentina
    • 10.4.3. Rest of South America
  • 10.5. Middle East & Africa
    • 10.5.1. Kingdom of Saudi Arabia
    • 10.5.2. United Arab Emirates
    • 10.5.3. Rest of Middle East & Africa

11. Company Profiles

  • 11.1. B. Braun Melsungen AG
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Cardinal Health
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Convatec Inc.
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Covalon Technologies Ltd.
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Coloplast Corp.
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Dermarite Industries LLC.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Johnson & Johnson
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Lohmann & Rauscher
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Medline Industries Inc.
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Paul Hartmann AG
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary
    • 11.10.4. Recent developments
  • 11.11. Smith & Nephew
    • 11.11.1. Company details
    • 11.11.2. Financial outlook
    • 11.11.3. Product summary
    • 11.11.4. Recent developments
  • 11.12. 3M
    • 11.12.1. Company details
    • 11.12.2. Financial outlook
    • 11.12.3. Product summary
    • 11.12.4. Recent developments